» Articles » PMID: 21761875

Photochemical Control of DNA Decoy Function Enables Precise Regulation of Nuclear Factor κB Activity

Overview
Journal J Am Chem Soc
Specialty Chemistry
Date 2011 Jul 19
PMID 21761875
Citations 26
Authors
Affiliations
Soon will be listed here.
Abstract

DNA decoys have been developed for the inhibition of transcriptional regulation of gene expression. However, the present methodology lacks the spatial and temporal control of gene expression that is commonly found in nature. Here, we report the application of photoremovable protecting groups on nucleobases of nuclear factor κB (NF-κB) DNA decoys to regulate NF-κB-driven transcription of secreted alkaline phosphatase using light as an external control element. The NF-κB family of proteins is comprised of important eukaryotic transcription factors that regulate a wide range of cellular processes and are involved in immune response, development, cellular growth, and cell death. Several diseases, including cancer, arthritis, chronic inflammation, asthma, neurodegenerative diseases, and heart disease, have been linked to constitutively active NF-κB. Through the direct incorporation of caging groups into an NF-κB decoy, we were able to disrupt DNA:DNA hybridization and inhibit the binding of the transcription factor to the DNA decoy until UV irradiation removed the caging groups and restored the activity of the oligonucleotide. Excellent light-switching behavior of transcriptional regulation was observed. This is the first example of a caged DNA decoy for the photochemical regulation of gene expression in mammalian cells and represents an important addition to the toolbox of light-controlled gene regulatory agents.

Citing Articles

Sequence-independent, site-specific incorporation of chemical modifications to generate light-activated plasmids.

Chung K, Booth M Chem Sci. 2023; 14(44):12693-12706.

PMID: 38020373 PMC: 10646958. DOI: 10.1039/d3sc02761a.


Expanding Catch and Release DNA Decoy (CRDD) Technology with Pyrimidine Mimics.

Kennelly S, Moorthy R, Silva Otero R, Harki D Chemistry. 2022; 28(58):e202201355.

PMID: 35849314 PMC: 9588621. DOI: 10.1002/chem.202201355.


PROTACs: great opportunities for academia and industry (an update from 2020 to 2021).

He M, Cao C, Ni Z, Liu Y, Song P, Hao S Signal Transduct Target Ther. 2022; 7(1):181.

PMID: 35680848 PMC: 9178337. DOI: 10.1038/s41392-022-00999-9.


Site-specific photolabile roadblocks for the study of transcription elongation in biologically complex systems.

Nadon J, Epshtein V, Cameron E, Samatov M, Vasenko A, Nudler E Commun Biol. 2022; 5(1):457.

PMID: 35552496 PMC: 9098449. DOI: 10.1038/s42003-022-03382-0.


Photochemical modifications for DNA/RNA oligonucleotides.

Tavakoli A, Min J RSC Adv. 2022; 12(11):6484-6507.

PMID: 35424630 PMC: 8982246. DOI: 10.1039/d1ra05951c.


References
1.
Osako M, Tomita N, Nakagami H, Kunugiza Y, Yoshino M, Yuyama K . Increase in nuclease resistance and incorporation of NF-kappaB decoy oligodeoxynucleotides by modification of the 3'-terminus. J Gene Med. 2007; 9(9):812-9. DOI: 10.1002/jgm.1077. View

2.
Dmochowski I, Tang X . Taking control of gene expression with light-activated oligonucleotides. Biotechniques. 2007; 43(2):161, 163, 165 passim. DOI: 10.2144/000112519. View

3.
Mayer G, Heckel A . Biologically active molecules with a "light switch". Angew Chem Int Ed Engl. 2006; 45(30):4900-21. DOI: 10.1002/anie.200600387. View

4.
Casey J, Blidner R, Monroe W . Caged siRNAs for spatiotemporal control of gene silencing. Mol Pharm. 2009; 6(3):669-85. DOI: 10.1021/mp900082q. View

5.
Lin Y, Bai L, Chen W, Xu S . The NF-kappaB activation pathways, emerging molecular targets for cancer prevention and therapy. Expert Opin Ther Targets. 2009; 14(1):45-55. PMC: 3043547. DOI: 10.1517/14728220903431069. View